Skip to main content
Signal8

Glancy Donovan Michael

SEC insider (Form 3/4/5 filer). CIK 0002134015. Director at COLLEGIUM PHARMACEUTICAL, INC (COLL). 1 reported Form 4/5 transaction since Sep 2024; latest on May 14, 2026. Located in STOUGHTON, MA.

Companies Glancy Donovan Michael has filed insider reports for

  • COLLEGIUM PHARMACEUTICAL, INC (COLL): Director
Glancy Donovan Michael profile photo

Glancy Donovan Michael

CIK: 0002134015

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COLLEGIUM PHARMACEUTICAL, INC logo
COLL

COLLEGIUM PHARMACEUTICAL, INC

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • COLLEGIUM PHARMACEUTICAL, INC logo
    COLL

    COLLEGIUM PHARMACEUTICAL, INC

    May 14, 2026
    Award
    Direct
    17.5K shares-

1-1 of 1